Clinical Trial Update: GINECO-EN102b - BKM120 as Monotherapy in the Treatment of Initial or Recurrent Metastatic Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of BKM120 as monotherapy for initial or recurrent metastatic endometrial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• BKM120 (Buparlisib)

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED